Edgewise Therapeutics, Inc. Profile Avatar - Palmy Investing

Edgewise Therapeutics, Inc.

Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystr…

Biotechnology
US, Boulder [HQ]
Value per Employee (VpE) · Surveys · Talents

Employees Analysis

Employee Surveys

Employees Asked: -

No survey available at the moment.

End of EWTX's Analysis
CIK: 1710072 CUSIP: 28036F105 ISIN: US28036F1057 LEI: - UEI: -
Secondary Listings
EWTX has no secondary listings inside our databases.